Psoriatic Arthritis Trial, Recruiting NCT06730334 Sponsor: Nanjing Medical University Condition: Psoriatic Arthritis
Back to Psoriatic Arthritis

Psoriatic Arthritis Trial, Recruiting

NCT06730334
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Psoriatic Arthritis (PsA) based on a specific set of medical guidelines called the CASPAR criteria.
  • You are able to attend all scheduled visits and follow the study plan, including any required tests and procedures.
  • You are willing and able to give your informed consent to take part in the study.

Who may not be able to join:

  • You have been diagnosed with another type of arthritis in the last 12 months.
  • You currently have or have a history of an infectious disease, whether short-term or long-lasting.
  • You are pregnant or currently breastfeeding.
  • You have difficulty tolerating blood draws, as the study requires blood samples to be taken.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 15951871668

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanjing Medical University
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Madrid Sonographic Enthesitis Index (MASEI); DACTylitis glObal Sonographic (DACTOS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov